Better Health Care ETF: Fidelity's FHLC vs. State Street's XLV

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• XLV generated a growth of $1,284 from a $1,000 investment over five years on a total return basis, outperforming FHLC's $1,231 over the same period despite lower 1-year return

  60% confidence

• XLV offers superior liquidity and a higher trailing-12-month dividend yield compared to FHLC, making it more suitable for income-seeking investors

  60% confidence

• FHLC has a trailing-12-month dividend of $1.01 per share, and its broader MSCI-based index captures small- and mid-cap companies that XLV skips

  60% confidence

• XLV has paid $2.51 per share in distributions over the trailing 12 months, with a dividend yield of 1.7% versus FHLC's 1.4%

  60% confidence

• FHLC provides broader market-cap exposure including mid- and small-cap stocks, capturing companies that XLV skips by tracking only S&P 500 healthcare components

  60% confidence

Data points we hold from this source